SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. Logo

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

A contract research organization providing preclinical and clinical services for medical industries.

2395 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
鹿児島市宮之浦町2438番地
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Shin Nippon Biomedical Laboratories, Ltd. (SNBL), established in 1957 as Japan's pioneering contract research organization (CRO), offers comprehensive drug development support services. The company specializes in preclinical and nonclinical safety studies, translational research, and clinical trial services for the pharmaceutical, medical device, and regenerative medicine industries. A key area of innovation includes the research and development of its proprietary nasal delivery system (NDS), the μco™ System. SNBL's mission is to free patients from suffering by supporting the creation of advanced medical technologies and novel pharmaceuticals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 08:58
Post-Annual General Meeting Information
臨時報告書
Japanese 24.7 KB
2025-06-27 07:46
Regulatory News Service
確認書
Japanese 8.2 KB
2025-06-27 07:40
Regulatory News Service
内部統制報告書-第52期(2024/04/01-2025/03/31)
Japanese 23.5 KB
2025-06-27 07:32
Annual Report
有価証券報告書-第52期(2024/04/01-2025/03/31)
Japanese 3.0 MB
2024-11-06 04:17
Report Publication Announcement
確認書
Japanese 10.8 KB
2024-11-06 04:11
Interim Report
半期報告書-第52期(2024/04/01-2025/03/31)
Japanese 253.7 KB
2024-06-26 04:52
Regulatory News Service
臨時報告書
Japanese 24.6 KB
2024-06-25 07:06
Regulatory News Service
確認書
Japanese 8.2 KB
2024-06-25 06:57
Governance Information
内部統制報告書-第51期(2023/04/01-2024/03/31)
Japanese 22.5 KB
2024-06-25 06:38
Annual Report
有価証券報告書-第51期(2023/04/01-2024/03/31)
Japanese 3.2 MB
2024-02-02 03:40
Report Publication Announcement
確認書
Japanese 10.8 KB
2024-02-02 03:39
Quarterly Report
四半期報告書-第51期第3四半期(2023/10/01-2023/12/31)
Japanese 203.9 KB
2023-11-07 07:18
Report Publication Announcement
確認書
Japanese 10.8 KB
2023-11-07 07:08
Quarterly Report
四半期報告書-第51期第2四半期(2023/07/01-2023/09/30)
Japanese 248.6 KB
2023-08-02 05:34
Report Publication Announcement
確認書
Japanese 10.8 KB

Automate Your Workflow. Get a real-time feed of all SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Ureru Net Advertising Group Co.,Ltd. Logo
Direct marketing support for D2C e-commerce, boosting sales with patented tech & cloud services.
Japan 9235
Urteste S.A. Logo
Develops non-invasive urine tests to detect cancers early by measuring enzyme activity.
Poland URT
VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan 3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan 6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan 7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea 094850
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden VIVE
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea 310210
WDB coco CO.,LTD. Logo
CRO for pharma & med devices specializing in safety info, PMS & full lifecycle support.
Japan 7079

Talk to a Data Expert

Have a question? We'll get back to you promptly.